- Home
- ADXN vs EKSO Comparison
ADXN vs EKSO Comparison
Compare ADXN & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- EKSO
- Stock Information
- Founded
- ADXN 2002
- EKSO 2005
- Country
- ADXN Switzerland
- EKSO United States
- Employees
- ADXN N/A
- EKSO N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- ADXN Health Care
- EKSO Health Care
- Exchange
- ADXN Nasdaq
- EKSO Nasdaq
- Market Cap
- ADXN 8.0M
- EKSO 7.7M
- IPO Year
- ADXN N/A
- EKSO N/A
- Fundamental
- Price
- ADXN $8.73
- EKSO $3.55
- Analyst Decision
- ADXN Strong Buy
- EKSO Strong Buy
- Analyst Count
- ADXN 1
- EKSO 2
- Target Price
- ADXN $30.00
- EKSO $34.75
- AVG Volume (30 Days)
- ADXN 1.0K
- EKSO 112.6K
- Earning Date
- ADXN 09-01-2025
- EKSO 07-28-2025
- Dividend Yield
- ADXN N/A
- EKSO N/A
- EPS Growth
- ADXN N/A
- EKSO N/A
- EPS
- ADXN 0.10
- EKSO N/A
- Revenue
- ADXN $278,508.00
- EKSO $14,651,000.00
- Revenue This Year
- ADXN $86.57
- EKSO $0.20
- Revenue Next Year
- ADXN N/A
- EKSO $42.29
- P/E Ratio
- ADXN $0.72
- EKSO N/A
- Revenue Growth
- ADXN N/A
- EKSO N/A
- 52 Week Low
- ADXN $6.51
- EKSO $2.73
- 52 Week High
- ADXN $13.27
- EKSO $19.20
- Technical
- Relative Strength Index (RSI)
- ADXN 58.21
- EKSO 53.12
- Support Level
- ADXN $7.51
- EKSO $3.01
- Resistance Level
- ADXN $8.21
- EKSO $3.31
- Average True Range (ATR)
- ADXN 0.17
- EKSO 0.21
- MACD
- ADXN 0.11
- EKSO 0.04
- Stochastic Oscillator
- ADXN 100.00
- EKSO 98.47
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.